Edition:
United States

Search Results  for '600812.SS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

North China Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Sep 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - North China Pharmaceutical Co Ltd (600812-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

23 Sep 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for North China Pharmaceutical, Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

16 Sep 2016 Wright Reports 65 $75.00

North China Pharmaceutical Co., Ltd. (600812) - Financial Analysis Review

North China Pharmaceutical Co., Ltd. (600812) - Financial Analysis Review Summary North China Pharmaceutical Co., Ltd. (NCPC)...

13 Sep 2016 GlobalData 34 $300.00

North China Pharmaceutical Co., Ltd. (600812) - Financial Analysis Review

North China Pharmaceutical Co., Ltd. (600812) - Financial Analysis Review Summary North China Pharmaceutical Co., Ltd. (NCPC)...

16 Jun 2016 GlobalData 34 $300.00

Thomson Reuters Stock Report - North China Pharmaceutical Co Ltd (600812-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 11 $25.00

North China Pharmaceutical Co., Ltd. (600812) - Financial Analysis Review

North China Pharmaceutical Co., Ltd. (600812) - Financial Analysis Review Summary North China Pharmaceutical Co., Ltd. (NCPC)...

14 Mar 2016 GlobalData 33 $300.00

North China Pharmaceutical Co., Ltd.: Upgraded to Average

18 Feb 2016 Sadif Analytics Prime 3 $10.00

North China Pharmaceutical Co., Ltd. (600812) - Financial Analysis Review

North China Pharmaceutical Co., Ltd. (600812) - Financial Analysis Review Summary North China Pharmaceutical Co., Ltd. (NCPC)...

11 Dec 2015 GlobalData 36 $300.00

North China Pharmaceutical Co., Ltd.: Downgraded to Risky

17 Nov 2015 Sadif Analytics Prime 3 $10.00